Literature DB >> 8496683

KBF1 (p50 NF-kappa B homodimer) acts as a repressor of H-2Kb gene expression in metastatic tumor cells.

D Plaksin1, P A Baeuerle, L Eisenbach.   

Abstract

Downregulation of major histocompatibility complex class I expression is causally related to high malignancy and low immunogenicity of certain murine tumors. In this study, we have analyzed the roles of the nuclear factors KBF1/p50 and p65 in regulation of class I expression in high and low metastatic tumor cells. Low class I-expressing cells show at higher levels of KBF1/p50 and NF-kappa B (p50/p65) binding activity than high class I-expressing cells. However, an excess of KBF1 over NF-kappa B is observed in low expressing cells, while an excess of NF-kappa B over KBF1 is observed in high expressing cells. Stable transfection of a p65 expression vector into low class I-expressing cells activated H-2 transcription and cell surface expression, while stable transfection of p50 expression vector into high expressing cells suppressed H-2Kb transcription and cell surface expression. Our studies suggest that KBF1 has the potential of downregulating class I gene expression, whereas dimers containing the p65 subunit are activators of class I gene expression.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8496683      PMCID: PMC2191052          DOI: 10.1084/jem.177.6.1651

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  80 in total

1.  Presentation of antigenic peptides by MHC class I molecules.

Authors:  G M van Bleek; S G Nathenson
Journal:  Trends Cell Biol       Date:  1992-07       Impact factor: 20.808

2.  Cloning of the p50 DNA binding subunit of NF-kappa B: homology to rel and dorsal.

Authors:  S Ghosh; A M Gifford; L R Riviere; P Tempst; G P Nolan; D Baltimore
Journal:  Cell       Date:  1990-09-07       Impact factor: 41.582

Review 3.  Antigen presentation: structural themes and functional variations.

Authors:  T J Braciale; V L Braciale
Journal:  Immunol Today       Date:  1991-04

4.  DNA sequence analysis of the C3H H-2Kk and H-2Dk loci. Evolutionary relationships to H-2 genes from four other mouse strains.

Authors:  S Watts; J M Vogel; W D Harriman; T Itoh; H J Stauss; R S Goodenow
Journal:  J Immunol       Date:  1987-12-01       Impact factor: 5.422

5.  H-2-restricted cytolytic T cells specific for HLA can recognize a synthetic HLA peptide.

Authors:  J L Maryanski; P Pala; G Corradin; B R Jordan; J C Cerottini
Journal:  Nature       Date:  1986 Dec 11-17       Impact factor: 49.962

6.  Detailed analysis of the mouse H-2Kb promoter: enhancer-like sequences and their role in the regulation of class I gene expression.

Authors:  A Kimura; A Israël; O Le Bail; P Kourilsky
Journal:  Cell       Date:  1986-01-31       Impact factor: 41.582

7.  Selective changes in expression of HLA class I polymorphic determinants in human solid tumors.

Authors:  P G Natali; M R Nicotra; A Bigotti; I Venturo; L Marcenaro; P Giacomini; C Russo
Journal:  Proc Natl Acad Sci U S A       Date:  1989-09       Impact factor: 11.205

8.  Altered binding of regulatory factors to HLA class I enhancer sequence in human tumor cell lines lacking class I antigen expression.

Authors:  O Blanchet; J F Bourge; H Zinszner; A Israel; P Kourilsky; J Dausset; L Degos; P Paul
Journal:  Proc Natl Acad Sci U S A       Date:  1992-04-15       Impact factor: 11.205

9.  The role of the p50 and p65 subunits of NF-kappa B in the recognition of cognate sequences.

Authors:  M B Urban; P A Baeuerle
Journal:  New Biol       Date:  1991-03

10.  Monoclonal antibodies to mouse MHC antigens. III. Hybridoma antibodies reacting to antigens of the H-2b haplotype reveal genetic control of isotype expression.

Authors:  K Ozato; D H Sachs
Journal:  J Immunol       Date:  1981-01       Impact factor: 5.422

View more
  41 in total

1.  Sequences between the enhancer and promoter in the long terminal repeat affect murine leukemia virus pathogenicity and replication in the thymus.

Authors:  F K Yoshimura; T Wang; M Cankovic
Journal:  J Virol       Date:  1999-06       Impact factor: 5.103

2.  Functional consequences of a polymorphism affecting NF-kappaB p50-p50 binding to the TNF promoter region.

Authors:  I A Udalova; A Richardson; A Denys; C Smith; H Ackerman; B Foxwell; D Kwiatkowski
Journal:  Mol Cell Biol       Date:  2000-12       Impact factor: 4.272

3.  Constitutive expression of Bc1-3 in thymocytes increases the DNA binding of NF-kappaB1 (p50) homodimers in vivo.

Authors:  J H Caamaño; P Perez; S A Lira; R Bravo
Journal:  Mol Cell Biol       Date:  1996-04       Impact factor: 4.272

4.  Nuclear factor-kappaB binds to the Epstein-Barr Virus LMP1 promoter and upregulates its expression.

Authors:  Pegah Johansson; Ann Jansson; Ulla Rüetschi; Lars Rymo
Journal:  J Virol       Date:  2008-11-19       Impact factor: 5.103

5.  Identification and functional comparison of seven-transmembrane G-protein-coupled BILF1 receptors in recently discovered nonhuman primate lymphocryptoviruses.

Authors:  Katja Spiess; Suzan Fares; Alexander H Sparre-Ulrich; Ellen Hilgenberg; Michael A Jarvis; Bernhard Ehlers; Mette M Rosenkilde
Journal:  J Virol       Date:  2014-12-10       Impact factor: 5.103

Review 6.  Chemical modulation of transcription factors.

Authors:  Bianca Wiedemann; Jörn Weisner; Daniel Rauh
Journal:  Medchemcomm       Date:  2018-07-11       Impact factor: 3.597

7.  NF-kappaB mediates mitogen-activated protein kinase pathway-dependent iNOS expression in human melanoma.

Authors:  Deon G Uffort; Elizabeth A Grimm; Julie A Ellerhorst
Journal:  J Invest Dermatol       Date:  2008-07-31       Impact factor: 8.551

8.  Targeted disruption of NF-{kappa}B1 (p50) augments cigarette smoke-induced lung inflammation and emphysema in mice: a critical role of p50 in chromatin remodeling.

Authors:  Saravanan Rajendrasozhan; Sangwoon Chung; Isaac K Sundar; Hongwei Yao; Irfan Rahman
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2009-12-04       Impact factor: 5.464

9.  IKKalpha, IKKbeta, and NEMO/IKKgamma are each required for the NF-kappa B-mediated inflammatory response program.

Authors:  Xiang Li; Paul E Massa; Adedayo Hanidu; Gregory W Peet; Patrick Aro; Ann Savitt; Sheenah Mische; Jun Li; Kenneth B Marcu
Journal:  J Biol Chem       Date:  2002-09-06       Impact factor: 5.157

Review 10.  Regulation of IkappaBalpha function and NF-kappaB signaling: AEBP1 is a novel proinflammatory mediator in macrophages.

Authors:  Amin Majdalawieh; Hyo-Sung Ro
Journal:  Mediators Inflamm       Date:  2010-04-12       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.